Premium Reports
2015 Best in KLAS Awards

2015 Best in KLAS Awards
Medical Equipment

| Read Time: Unknown

Reflecting the provider voice, this report ranks the best-performing imaging and pharmacy automation equipment covering more than 60 products, including pharmacy automation, CT, MR, ultrasound, among others. The research enables providers to make more-informed technology decisions and helps vendors strive for excellence. Download the report to find out how well your vendors and prospective vendors perform, which vendors keep their promises best, and which offerings best meet customer expectations. Want to see how your healthcare IT vendors perform? Download the July 2015 Mid-Term Performance Review: Software & Services.

IMAGING EQUIPMENT

COMPUTED TOMOGRAPHY (CT)

Siemens CT 86.8

MAMMOGRAPHY

Hologic Mammography 91.4

MAGNETIC RESONANCE (MR)

Siemens MR 85.8

RADIATION THERAPY

Elekta Radiation Therapy 86.5

ULTRASOUND

Toshiba Ultrasound 86.7

X-RAY

Shimadzu X-ray 87.0

PHARMACY AUTOMATION EQUIPMENT

AUTOMATED MEDICATION DISPENSING UNITS

Omnicell OmniRx 86.4

SMART PUMPS

CareFusion Alaris 85.2



IMAGING EQUIPMENT

CV/IR X-RAY

Siemens CV/IR 85.6

PHARMACY AUTOMATION EQUIPMENT

ANESTHESIA CABINETS

Omnicell Anesthesia Workstation 86.3

PHARMACY AUTOMATION: HIGH-VOLUME UNIT DOSE PACKAGING

ARxIUM FastPak EXP (ABTG) 78.4

PHARMACY AUTOMATION: IV ROBOTS

ARxIUM RIVA (IH Systems) 87.1

PHARMACY AUTOMATION: MEDICATION CABINETS

Omnicell WorkflowRx Carousel 85.4

PHARMACY AUTOMATION: ROBOTS (ORAL SOLID)

Aesynt PROmanager-Rx 83.4

Want to see full details?

 Download Report Brief  Download Full Report

This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2018 KLAS Enterprises, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.